Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11 (NDUFA5P11)

Target
NDUFA5P11
Molecular classification
Other (Pseudogene; it does not fit into classic categories like enzyme, receptor, or transporter)
01

Overview

NDUFA5P11, or NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11, is a pseudogene related to a subunit of mitochondrial complex I. Unlike its functional parent gene (NDUFA5), NDUFA5P11 does not produce a functional protein. Pseudogenes are DNA segments that resemble known genes but lack coding potential due to mutations, deletions, or premature stop codons. Traditionally considered "genomic fossils," some pseudogenes, when transcribed, can nonetheless regulate parental genes or other cellular processes through their RNA. Functions of this kind include microRNA decoying, antisense regulation, or generating small interfering RNAs, though there is no documented evidence of NDUFA5P11 playing any such role[5]. It is not currently considered a direct therapeutic target, nor is it known to participate in drug interactions, serve as a biomarker, or present safety concerns for therapy.

Other names
NDUFA5P11NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 pseudogene
02

Mechanism of action

Null (No mechanisms of action; therapeutic modulation is not applicable.)

03

Biological functions

Null (No known functional protein product; if expressed, its RNA could play regulatory roles typical for pseudogenes, such as miRNA sponging or antisense regulation)
04

Disease associations

Null or Other (No direct disease role has been established; some pseudogenes can modulate expression of functional genes and have been implicated in disease regulation, but no specific disease role is documented for NDUFA5P11)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11 (NDUFA5P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11 (NDUFA5P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call